| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.02 | 0.8 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.8 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |